Ultrasound/microbubble-mediated targeted delivery of anticancer microRNA-loaded nanoparticles to deep tissues in pigs.

J Control Release 2019 Sep 18;309:1-10. Epub 2019 Jul 18.

Department of Radiology, School of Medicine, Stanford University, Stanford, California, United States of America.

In this study, we designed and validated a platform for ultrasound and microbubble-mediated delivery of FDA-approved pegylated poly lactic-co-glycolic acid (PLGA) nanoparticles loaded with anticancer microRNAs (miRNAs) to deep tissues in a pig model. Small RNAs have been shown to reprogram tumor cells and sensitize them to clinically used chemotherapy. To overcome their short intravascular circulation half-life and achieve controlled and sustained release into tumor cells, anticancer miRNAs need to be encapsulated into nanocarriers. Focused ultrasound combined with gas-filled microbubbles provides a noninvasive way to improve the permeability of tumor vasculature and increase the delivery efficiency of drug-loaded particles. A single handheld, curvilinear ultrasound array was used in this study for image-guided therapy with clinical-grade SonoVue contrast agent. First, we validated the platform on phantoms to optimize the microbubble cavitation dose based on acoustic parameters, including peak negative pressure, pulse length, and pulse repetition frequency. We then tested the system in vivo by delivering PLGA nanoparticles co-loaded with antisense-miRNA-21 and antisense-miRNA-10b to pig liver and kidney. Enhanced miRNA delivery was observed (1.9- to 3.7-fold increase) as a result of the ultrasound treatment compared to untreated control regions. Additionally, we used highly fluorescent semiconducting polymer nanoparticles to visually assess nanoparticle extravasation. Fluorescent microscopy suggested the presence of nanoparticles in the extravascular compartment. Hematoxylin and eosin staining of treated tissues did not reveal tissue damage. The results presented in this manuscript suggest that the proposed platform may be used to safely and noninvasively enhance the delivery of miRNA-loaded nanoparticles to target regions in deep organs in large animal models.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jconrel.2019.07.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815710PMC
September 2019
4 Reads

Publication Analysis

Top Keywords

validated platform
8
deep tissues
8
plga nanoparticles
8
tumor cells
8
nanoparticles
6
delivery
5
repetition frequency
4
frequency tested
4
including peak
4
tested system
4
pulse repetition
4
peak negative
4
pulse length
4
negative pressure
4
system vivo
4
length pulse
4
pressure pulse
4
nanoparticles co-loaded
4
kidney enhanced
4
liver kidney
4

Similar Publications